Kalobios Pharmaceuticals Inc

(KBIO)

By |

Profile

KaloBios Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in the development of monoclonal antibody therapeutics for diseases that burdens the society and to patients and their families.

Issuer Information

NAICS: Pharmaceutical P
$ 4.30 ($ 0.19) (-4.23%)
Last Price 4.30 Change $ -0.19 Change % -4.23 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 4.75 High 4.75 Low 4.10 Prev Close 4.49
Last Trade Volume 17,705 52 Wk Hi 31.30 52 Wk Low 1.02
Market Cap 64.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 14,903,022.00 EPS (TTM) -7.32 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 12
Number of Buys 2 12
Number of Sells 0 0
Net Activity 229369 1909010
Last 10 Buys Shares
Michael Harrison 1,000
Thomas Edward Fernandez 1,000
Marek Biestek 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Martin Shkreli 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 5 5 5 5
Mean Target Price Estimate 5 5 5 5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/11/14 11/11/14 11/11/14 11/11/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1

News